导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.29% | 2271/4773 |
| 近一周 | -3.78% | 4589/5462 |
| 近一月 | -10.83% | 5214/5421 |
| 近一季 | -21.17% | 5015/5209 |
| 近半年 | -2.22% | 1826/4920 |
| 近一年 | 5.24% | 1624/4366 |
| 近两年 | 117.70% | 412/2954 |
| 近三年 | 75.72% | 248/2253 |
| 成立以来 | 172.44% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.42% 2292/4961 |
36.84% 880/5312 |
- - |
- - |
| 2025 | 55.02% 342/4813 |
-3.34% 3044/3635 |
3.88% 925/4076 |
55.50% 181/4524 |
-0.72% 2610/4813 |
| 2024 | 20.47% 466/3463 |
-1.69% 1263/2808 |
-6.63% 1989/3014 |
30.93% 122/3129 |
0.24% 1243/3463 |
| 2023 | -22.25% 1925/2656 |
-0.65% 1817/2280 |
-7.76% 1906/2385 |
-10.01% 1933/2515 |
-5.72% 1475/2655 |
| 2022 | -28.26% 1543/2207 |
-19.61% 1480/1919 |
6.82% 599/2016 |
-18.71% 1732/2113 |
2.78% 836/2208 |
| 2021 | 15.25% 308/1822 |
-5.71% 947/1255 |
29.79% 48/1330 |
-6.64% 971/1466 |
0.88% 1048/1822 |
| 2020 | 77.52% 48/1250 |
4.20% 82/1028 |
32.08% 34/1067 |
8.18% 728/1164 |
19.22% 79/1184 |
| 2019 | - - |
- - |
- - |
7.89% 74/850 |
14.05% 27/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华安创业板50ETF联接C VS. 长安沪深300非周期A(740101) |